Glycobiology Advance Access originally published online on January 12, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glycobiology vol 14 no 4 pp. 17R-30R, 2004
Glycobiology vol. 14 no. 4 © Oxford University Press 2004; all rights reserved.
REVIEW |
Interactions of heparin/heparan sulfate with proteins: Appraisal of structural factors and experimental approaches
School of Biological Sciences, Biosciences Building, University of Liverpool, Crown Street, Liverpool, L69 7ZB, United Kingdom
Received on July 3, 2003; accepted on December 19, 2003
Over the past decade, the glycosaminoglycans heparin and heparan sulfate have been shown to bind and regulate the activities of many proteins. Established techniques have provided both qualitative and quantitative information regarding these interactions, leading to a general view that proteins bind with a variety of affinities to particular sequences within heparin or heparan sulfate chains. The mechanism by which heparan sulfate regulates the activity of proteins through such interactions has, however, proved more elusive. We survey some relevant details of the structural characteristics of heparin/heparan sulfate and the approaches used to investigate their interactions with proteins. For the latter, the interactions of heparin/heparan sulfate with fibroblast growth factors and their receptors will be emphasized, because these proteins have been the subject of many studies. We reflect on the information that various techniques have provided, points regarding their use, and some relevant theoretical considerations regarding the study of protein–heparin/heparan sulfate interactions. A perspective of new and developing approaches, which may aid advances in this field, is also provided.
1 To whom correspondence should be addressed; e-mail: andrew.powell{at}liverpool.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. M. Hossain, T. Hosono-Fukao, R. Tang, N. Sugaya, T. H van Kuppevelt, G. J Jenniskens, K. Kimata, S. D Rosen, and K. Uchimura Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88 Glycobiology, February 1, 2010; 20(2): 175 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Thompson, D. G. Fernig, E. C. Jesudason, P. D. Losty, E. M. A. van de Westerlo, T. H. van Kuppevelt, and J. E. Turnbull Heparan Sulfate Phage Display Antibodies Identify Distinct Epitopes with Complex Binding Characteristics: INSIGHTS INTO PROTEIN BINDING SPECIFICITIES J. Biol. Chem., December 18, 2009; 284(51): 35621 - 35631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kalia, V. Chandra, S. A. Rahman, D. Sehgal, and S. Jameel Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection J. Virol., December 15, 2009; 83(24): 12714 - 12724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wittrup, S.-H. Zhang, G. B. ten Dam, T. H. van Kuppevelt, P. Bengtson, M. Johansson, J. Welch, M. Morgelin, and M. Belting ScFv Antibody-induced Translocation of Cell-surface Heparan Sulfate Proteoglycan to Endocytic Vesicles: EVIDENCE FOR HEPARAN SULFATE EPITOPE SPECIFICITY AND ROLE OF BOTH SYNDECAN AND GLYPICAN J. Biol. Chem., November 20, 2009; 284(47): 32959 - 32967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Puvirajesinghe, S. E. Guimond, J. E. Turnbull, and S. Guenneau Chemometric analysis for comparison of heparan sulphate oligosaccharides J R Soc Interface, November 6, 2009; 6(40): 997 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jin, M. Hricovini, J. A Deakin, M. Lyon, and D. Uhrin Residual dipolar coupling investigation of a heparin tetrasaccharide confirms the limited effect of flexibility of the iduronic acid on the molecular shape of heparin Glycobiology, November 1, 2009; 19(11): 1185 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ori, P. Free, J. Courty, M. C. Wilkinson, and D. G. Fernig Identification of Heparin-binding Sites in Proteins by Selective Labeling Mol. Cell. Proteomics, October 1, 2009; 8(10): 2256 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Guimond, T. M. Puvirajesinghe, M. A. Skidmore, I. Kalus, T. Dierks, E. A. Yates, and J. E. Turnbull Rapid Purification and High Sensitivity Analysis of Heparan Sulfate from Cells and Tissues: TOWARD GLYCOMICS PROFILING J. Biol. Chem., September 18, 2009; 284(38): 25714 - 25722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. V. Victor, T. K. N. Nguyen, M. Ethirajan, V. M. Tran, K. V. Nguyen, and B. Kuberan Investigating the Elusive Mechanism of Glycosaminoglycan Biosynthesis J. Biol. Chem., September 18, 2009; 284(38): 25842 - 25853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ashikari-Hada, H. Habuchi, N. Sugaya, T. Kobayashi, and K. Kimata Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate Glycobiology, June 1, 2009; 19(6): 644 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mitsi, K. Forsten-Williams, M. Gopalakrishnan, and M. A. Nugent A Catalytic Role of Heparin within the Extracellular Matrix J. Biol. Chem., December 12, 2008; 283(50): 34796 - 34807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Hanoulle, A. Melchior, N. Sibille, B. Parent, A. Denys, J.-M. Wieruszeski, D. Horvath, F. Allain, G. Lippens, and I. Landrieu Structural and Functional Characterization of the Interaction between Cyclophilin B and a Heparin-derived Oligosaccharide J. Biol. Chem., November 23, 2007; 282(47): 34148 - 34158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Schenauer, Y. Yu, M. D. Sweeney, and J. A. Leary CCR2 Chemokines Bind Selectively to Acetylated Heparan Sulfate Octasaccharides J. Biol. Chem., August 31, 2007; 282(35): 25182 - 25188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. de Barros, L. R. Andrade, S. Allodi, C. Viskov, P. A. Mourier, M. C. M. Cavalcante, A. H. Straus, H. K. Takahashi, V. H. Pomin, V. F. Carvalho, et al. The Hemolymph of the Ascidian Styela plicata (Chordata-Tunicata) Contains Heparin inside Basophil-like Cells and a Unique Sulfated Galactoglucan in the Plasma J. Biol. Chem., January 19, 2007; 282(3): 1615 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ricard-Blum, M. Beraud, N. Raynal, R. W. Farndale, and F. Ruggiero Structural Requirements for Heparin/Heparan Sulfate Binding to Type V Collagen J. Biol. Chem., September 1, 2006; 281(35): 25195 - 25204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kreuger, D. Spillmann, J.-p. Li, and U. Lindahl Interactions between heparan sulfate and proteins: the concept of specificity J. Cell Biol., July 31, 2006; 174(3): 323 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Rubio-Gayosso, S. H. Platts, and B. R. Duling Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Robinson, N. J. Harmer, S. J. Goodger, T. L. Blundell, and J. T. Gallagher Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1{middle dot}FGFR2c{middle dot}Heparin Ternary Complexes J. Biol. Chem., December 23, 2005; 280(51): 42274 - 42282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yu, M. D. Sweeney, O. M. Saad, S. E. Crown, T. M. Handel, and J. A. Leary Chemokine-Glycosaminoglycan Binding: SPECIFICITY FOR CCR2 LIGAND BINDING TO HIGHLY SULFATED OLIGOSACCHARIDES USING FTICR MASS SPECTROMETRY J. Biol. Chem., September 16, 2005; 280(37): 32200 - 32208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Lee, H.-H. Guan, C.-H. Wang, W.-N. Huang, S.-C. Tjong, C.-J. Chen, and W.-g. Wu Structural Basis of Citrate-dependent and Heparan Sulfate-mediated Cell Surface Retention of Cobra Cardiotoxin A3 J. Biol. Chem., March 11, 2005; 280(10): 9567 - 9577. [Abstract] [Full Text] [PDF]
|
|